296 related articles for article (PubMed ID: 22686617)
1. Bilastine: in allergic rhinitis and urticaria.
Carter NJ
Drugs; 2012 Jun; 72(9):1257-69. PubMed ID: 22686617
[TBL] [Abstract][Full Text] [Related]
2. Safety profile of bilastine: 2nd generation H1-antihistamines.
Scaglione F
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
Sastre J; Mullol J; Valero A; Valiente R;
Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
Novák Z; Yáñez A; Kiss I; Kuna P; Tortajada-Girbés M; Valiente R;
Pediatr Allergy Immunol; 2016 Aug; 27(5):493-8. PubMed ID: 26918853
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Abdelshafy AM; Abdallah SY; Hassan AF; Mohamed HA; Kamal NM; Ali ST; Abdelhaleem IA
Am J Rhinol Allergy; 2022 Sep; 36(5):684-694. PubMed ID: 35593100
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
Hide M; Yagami A; Togawa M; Saito A; Furue M
Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
9. How bilastine is used to treat allergic rhinitis and urticaria in children.
Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial.
Okubo K; Gotoh M; Togawa M; Saito A; Ohashi Y
Auris Nasus Larynx; 2017 Jun; 44(3):294-301. PubMed ID: 27561709
[TBL] [Abstract][Full Text] [Related]
11. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
12. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
[TBL] [Abstract][Full Text] [Related]
13. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
Bachert C; Kuna P; Sanquer F; Ivan P; Dimitrov V; Gorina MM; van de Heyning P; Loureiro A;
Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
[TBL] [Abstract][Full Text] [Related]
15. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
Bousquet J; Ansótegui I; Canonica GW; Zuberbier T; Baena-Cagnani CE; Bachert C; Cruz AA; González SN; Kuna P; Morais-Almeida M; Mullol J; Ryan DP; Sánchez-Borges M; Valiente R; Church MK
Curr Med Res Opin; 2012 Jan; 28(1):131-9. PubMed ID: 22149770
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of desloratadine for the management of allergic disease.
Berger WE
Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713
[TBL] [Abstract][Full Text] [Related]
17. Bilastine and quality of life.
Jáuregui I; Bartra J; del Cuvillo A; Dávila I; Ferrer M; Montoro J; Mullol J; Sastre J; Valero A
J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():16-23. PubMed ID: 22185046
[TBL] [Abstract][Full Text] [Related]
18. Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.
Wolthers OD
Biomed Res Int; 2013; 2013():626837. PubMed ID: 23956994
[TBL] [Abstract][Full Text] [Related]
19. Bilastine for the relief of allergy symptoms.
Sádaba Díaz de Rada B; Azanza Perea JR; Gomez-Guiu Hormigos A
Drugs Today (Barc); 2011 Apr; 47(4):251-62. PubMed ID: 21573249
[TBL] [Abstract][Full Text] [Related]
20. The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber.
Horak F; Zieglmayer P; Zieglmayer R; Lemell P
Inflamm Res; 2010 May; 59(5):391-8. PubMed ID: 19943178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
